Collegium Pharmaceutical (COLL) Current Assets (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Current Assets of $745.7 million for Q1 2026, up 41.34% year-over-year from $527.6 million in Q1 2025, and up 7.85% quarter-over-quarter from $691.4 million in Q4 2025.
Collegium Pharmaceutical (COLL) Current Assets (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Current Assets history runs 13 years deep, the most recent figure standing at $745.7 million for Q1 2026.
- In Q1 2026, Current Assets rose 41.34% year-over-year to $745.7 million; the TTM figure through Mar 2026 stood at $745.7 million (up 41.34% YoY), while the FY2025 annual figure was $691.4 million, up 43.37% from the prior year.
- Current Assets for Q1 2026 stood at $745.7 million, up from $691.4 million in the prior quarter.
- The five-year high for Current Assets was $745.7 million in Q1 2026, with the low at $363.6 million in Q1 2022.
- The 5-year median for Current Assets is $527.6 million (2025), against an average of $518.4 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets fell 17.37% in 2024, then soared 43.37% in 2025.
- Collegium Pharmaceutical's Current Assets stood at $420.0 million in 2022, then climbed by 28.0% to $537.6 million in 2023, then slipped by 10.29% to $482.3 million in 2024, then soared by 43.37% to $691.4 million in 2025, then climbed by 7.85% to $745.7 million in 2026.
- Business Quant data shows COLL's Current Assets at $745.7 million in Q1 2026, $691.4 million in Q4 2025, and $613.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 608.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 608.01 Mn |
| Mar 31, 2026 | 745.67 Mn |
| Dec 31, 2025 | 691.41 Mn |
| Sep 30, 2025 | 613.87 Mn |
| Jun 30, 2025 | 549.21 Mn |
| Mar 31, 2025 | 527.55 Mn |
| Dec 31, 2024 | 482.26 Mn |
| Sep 30, 2024 | 443.81 Mn |
| Jun 30, 2024 | 510.20 Mn |
| Mar 31, 2024 | 539.26 Mn |
| Dec 31, 2023 | 537.60 Mn |
| Sep 30, 2023 | 537.09 Mn |
| Jun 30, 2023 | 537.30 Mn |
| Mar 31, 2023 | 498.30 Mn |
| Dec 31, 2022 | 419.99 Mn |
| Sep 30, 2022 | 405.22 Mn |
| Jun 30, 2022 | 409.77 Mn |
| Mar 31, 2022 | 363.64 Mn |
| Dec 31, 2021 | 315.54 Mn |
| Sep 30, 2021 | 363.24 Mn |